相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Topical paromomycin for New World cutaneous leishmaniasis
Nestor Sosa et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania
Arijit Bhattacharya et al.
NATURE COMMUNICATIONS (2019)
What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil
Fernando T. Silveiraa
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Chemotherapy of leishmaniasis: present challenges
Silvia R. B. Uliana et al.
PARASITOLOGY (2018)
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome (R) and AmBisome (R) in murine cutaneous leishmaniasis
Gert-Jan Wijnant et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
Alberto Rastrojo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection
Carina Scolari Gosch et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin
Moran Shalev-Benami et al.
NATURE COMMUNICATIONS (2017)
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
Ridwanur Rahman et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Leishmaniasis drug discovery: recent progress and challenges in assay development
Bilal Zulfigar et al.
DRUG DISCOVERY TODAY (2017)
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
Gert-Jan Wijnant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Kazi M. Jamil et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species
Eliane de Morais-Teixeira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L-infantum
S. Hendrickx et al.
PARASITOLOGY RESEARCH (2014)
In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis
Adriano C. Coelho et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Susceptibility of clinical isolates of Leishrnania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model
M. Utaile et al.
EXPERIMENTAL PARASITOLOGY (2013)
Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: Validation of luciferase as a quantitative tool
Juliana Q. Reimao et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2013)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
Sarah Hendrickx et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil
Anette Chrusciak-Talhari et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Acute kidney injury: definition, epidemiology, and outcome
Nattachai Srisawat et al.
CURRENT OPINION IN CRITICAL CARE (2011)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin -Susceptible -Resistant Leishmania donovani
Bhavna Chawla et al.
PLOS ONE (2011)
Combination therapy for visceral leishmaniasis
Johan van Griensven et al.
LANCET INFECTIOUS DISEASES (2010)
Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial
Paulo R. Machado et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Paromomycin
Robert N. Davidson et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2009)
A real-time polymerase chain reaction assay for the identification and quantification of American Leishmania species on the basis of glucose-6-phosphate dehydrogenase
Tiago Moreno Castilho et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2008)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?
Suman Rijal et al.
MICROBES AND INFECTION (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
American tegumentary leishmaniasis:: Is antimonial treatment outcome related to parasite drug susceptibility?
Vanessa Yardley et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Treatment of visceral leishmaniasis
S Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages
DS Zamboni et al.
INFECTION AND IMMUNITY (2003)
Real-time PCR for detection and quantitation of Leishmania in mouse tissues
L Nicolas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala
BA Arana et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
分享论文
